Mereo BioPharma Group plc (MREO)

Latest Insider Confidence Score

2026Q1

50.0
Bearish

Company insider confidence (by quarter)

2024Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Rubric Capital Management LP 15,307,347 Jun 17, 2024
Rosen David Efraim 15,307,347 Jun 17, 2024
Scots-Knight Denise CEO 808,921 Sep 16, 2024
Sermon Charles General Counsel 219,061 Sep 16, 2024
Fox Christine Ann CFO 89,285 Sep 16, 2024

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 26, 2026 Feb 27, 2026 Jacquet Pierre Director Neutral 52.5 - 0.00% -
Feb 26, 2026 Feb 27, 2026 Yoskowitz Marc J Director Neutral 52.5 - 0.00% -
Feb 26, 2026 Feb 27, 2026 Shames Daniel Director Neutral 52.5 - 0.00% -
Feb 26, 2026 Feb 27, 2026 Ekblom Anders Director Neutral 52.5 - 0.00% -
Feb 26, 2026 Feb 27, 2026 Bender Jeremy Director Neutral 52.5 - 0.00% -
Feb 26, 2026 Feb 27, 2026 PAKIANATHAN DEEPIKA Director Neutral 52.5 - 0.00% -
Feb 26, 2026 Feb 27, 2026 Jenkins Annalisa Director Neutral 52.5 - 0.00% -
Feb 26, 2026 Feb 27, 2026 WYZGA MICHAEL S Director Neutral 52.5 - 0.00% -
Feb 1, 2026 Feb 2, 2026 Lewicki John A. Chief Scientific Officer Neutral 52.5 - 0.00% -
Feb 1, 2026 Feb 2, 2026 Hughes-Wilson Alexandra Officer Neutral 52.5 - 0.00% -
Feb 1, 2026 Feb 2, 2026 Sermon Charles General Counsel Neutral 52.5 - 0.00% -
Feb 1, 2026 Feb 2, 2026 Scots-Knight Denise CEO Neutral 52.5 - 0.00% -
Feb 1, 2026 Feb 2, 2026 Fox Christine Ann CFO Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 6, 2025 Yoskowitz Marc J Director Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 6, 2025 PAKIANATHAN DEEPIKA Director Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 6, 2025 Bender Jeremy Director Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 6, 2025 Ekblom Anders Director Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 6, 2025 WYZGA MICHAEL S Director Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 6, 2025 Shames Daniel Director Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 6, 2025 Jenkins Annalisa Director Neutral 52.5 - 0.00% -
Feb 5, 2025 Feb 6, 2025 Jacquet Pierre Director Neutral 52.5 - 0.00% -
Jan 25, 2025 Jan 28, 2025 Lewicki John A. Chief Scientific Officer Neutral 52.5 - 0.00% -
Jan 25, 2025 Jan 28, 2025 Fox Christine Ann CFO Neutral 52.5 - 0.00% -
Jan 25, 2025 Jan 28, 2025 Sermon Charles General Counsel Neutral 52.5 - 0.00% -
Jan 25, 2025 Jan 28, 2025 Hughes-Wilson Alexandra Officer Neutral 52.5 - 0.00% -
Jan 25, 2025 Jan 28, 2025 Scots-Knight Denise CEO Neutral 52.5 - 0.00% -
Sep 12, 2024 Sep 16, 2024 Scots-Knight Denise CEO Sell 40.0 -88,657 -9.88% $381.4K
Sep 12, 2024 Sep 16, 2024 Lewicki John A. Chief Scientific Officer Sell 42.5 -16,149 -14.82% $69.5K
Sep 12, 2024 Sep 16, 2024 Sermon Charles General Counsel Sell 42.5 -30,926 -12.37% $133.1K
Sep 12, 2024 Sep 16, 2024 Fox Christine Ann CFO Sell 42.5 -28,286 -24.06% $121.7K
Sep 12, 2024 Sep 16, 2024 Hughes-Wilson Alexandra Officer Sell 40.0 -148,110 -74.58% $637.2K
Sep 11, 2024 Sep 13, 2024 Sermon Charles General Counsel Neutral 52.5 - 0.00% -
Sep 11, 2024 Sep 13, 2024 Fox Christine Ann CFO Neutral 52.5 - 0.00% -
Sep 11, 2024 Sep 13, 2024 Lewicki John A. Chief Scientific Officer Neutral 52.5 - 0.00% -
Sep 11, 2024 Sep 13, 2024 Scots-Knight Denise CEO Neutral 52.5 - 0.00% -
Sep 11, 2024 Sep 13, 2024 Hughes-Wilson Alexandra Officer Neutral 52.5 - 0.00% -
Aug 22, 2024 Aug 23, 2024 PAKIANATHAN DEEPIKA Director Sell 20.0 -105,244 -100.00% $466.2K
Jun 25, 2024 Jun 27, 2024 Sermon Charles General Counsel Sell 42.5 -46,389 -20.10% $161.7K
Jun 25, 2024 Jun 27, 2024 Lewicki John A. Chief Scientific Officer Sell 42.5 -24,224 -27.78% $84.4K
Jun 25, 2024 Jun 27, 2024 Fox Christine Ann CFO Sell 42.5 -42,429 -42.43% $147.9K
Jun 25, 2024 Jun 27, 2024 Scots-Knight Denise CEO Sell 40.0 -132,985 -15.78% $463.5K
Jun 25, 2024 Jun 27, 2024 Hughes-Wilson Alexandra Officer Sell 42.5 -33,102 -48.93% $115.4K
Jun 21, 2024 Jun 25, 2024 Lewicki John A. Chief Scientific Officer Neutral 52.5 - 0.00% -
Jun 21, 2024 Jun 25, 2024 Scots-Knight Denise CEO Neutral 52.5 - 0.00% -
Jun 21, 2024 Jun 25, 2024 Sermon Charles General Counsel Neutral 52.5 - 0.00% -
Jun 21, 2024 Jun 25, 2024 Fox Christine Ann CFO Neutral 52.5 - 0.00% -
Jun 21, 2024 Jun 25, 2024 Hughes-Wilson Alexandra Officer Neutral 52.5 - 0.00% -
Jun 17, 2024 Jun 17, 2024 Rubric Capital Management LP 10% Owner Neutral 52.5 - 0.00% -
Jun 17, 2024 Jun 17, 2024 WYZGA MICHAEL S Director Neutral 90.0 +25,050 100.00% -
Jun 17, 2024 Jun 17, 2024 Bender Jeremy Director Neutral 90.0 +12,550 100.00% -
Jun 11, 2024 Hughes-Wilson Alexandra Officer Neutral 52.5 - 0.00% -
May 22, 2024 May 23, 2024 Hughes-Wilson Alexandra Officer Sell 20.0 -168,333 -61.25% $383.1K
Feb 8, 2024 Feb 9, 2024 Ekblom Anders Director Neutral 52.5 - 0.00% -
Feb 8, 2024 Feb 9, 2024 Jacquet Pierre Director Neutral 52.5 - 0.00% -
Feb 8, 2024 Feb 9, 2024 Yoskowitz Marc J Director Neutral 52.5 - 0.00% -
Feb 8, 2024 Feb 9, 2024 PAKIANATHAN DEEPIKA Director Neutral 52.5 - 0.00% -
Feb 8, 2024 Feb 9, 2024 WYZGA MICHAEL S Director Neutral 52.5 - 0.00% -
Feb 8, 2024 Feb 9, 2024 Shames Daniel Director Neutral 52.5 - 0.00% -
Feb 8, 2024 Feb 9, 2024 Jenkins Annalisa Director Neutral 52.5 - 0.00% -
Feb 8, 2024 Feb 9, 2024 Bender Jeremy Director Neutral 52.5 - 0.00% -
Jan 25, 2024 Jan 26, 2024 Sermon Charles General Counsel Neutral 52.5 - 0.00% -
Jan 25, 2024 Jan 26, 2024 Scots-Knight Denise CEO Neutral 52.5 - 0.00% -
Jan 25, 2024 Jan 26, 2024 Hughes-Wilson Alexandra Officer Neutral 52.5 - 0.00% -
Jan 25, 2024 Jan 26, 2024 Lewicki John A. Chief Scientific Officer Neutral 52.5 - 0.00% -
Jan 25, 2024 Jan 26, 2024 Fox Christine Ann CFO Neutral 52.5 - 0.00% -
Jan 2, 2024 Ekblom Anders Director Neutral 52.5 - 0.00% -
Jan 2, 2024 Sermon Charles General Counsel Neutral 52.5 - 0.00% -
Jan 2, 2024 Shames Daniel Director Neutral 52.5 - 0.00% -
Jan 2, 2024 Hughes-Wilson Alexandra Officer Neutral 52.5 - 0.00% -
Jan 2, 2024 PAKIANATHAN DEEPIKA Director Neutral 52.5 - 0.00% -
Jan 2, 2024 Fox Chrisitne Ann CFO Neutral 52.5 - 0.00% -
Jan 2, 2024 Jenkins Annalisa Director Neutral 52.5 - 0.00% -
Jan 2, 2024 Lewicki John A. Chief Scientific Officer Neutral 52.5 - 0.00% -
Jan 2, 2024 Scots-Knight Denise CEO Neutral 52.5 - 0.00% -
Jan 2, 2024 WYZGA MICHAEL S Director Neutral 52.5 - 0.00% -
Jan 2, 2024 Jacquet Pierre Director Neutral 52.5 - 0.00% -
Jan 2, 2024 Yoskowitz Marc J Director Neutral 52.5 - 0.00% -
Jan 2, 2024 Roberts Justin Hunter Director Neutral 52.5 - 0.00% -
Jan 2, 2024 Bender Jeremy Director Neutral 52.5 - 0.00% -
Jan 2, 2024 Rubric Capital Management LP 10% Owner Neutral 52.5 - 0.00% -